Tapping Africa’s health investment opportunity
Africa’s disease burden has been gradually edging down as investments in advanced health systems and the right medical infrastructure gains momentum. CNBC Africa spoke to David Fredrickson, Executive Vice President, Oncology Business, Astrazeneca for more on the investment opportunities.
Tue, 02 Jul 2024 10:47:08 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- Collaboration with Governments to Address Specific Healthcare Needs
- Tailoring Programs for Affordability and Accessibility
- Capacity Building, Training, and Advocacy as Key Strategies
Investing in advancing health systems and developing the right medical infrastructure in Africa has been gaining momentum, leading to a gradual decrease in the disease burden across the continent. CNBC Africa recently interviewed Dr. David Fredrickson, the Executive Vice President of AstraZeneca's Oncology Business, to delve into the investment opportunities in Africa's healthcare sector. AstraZeneca's mission is to improve global health outcomes for individuals, society, and the planet. Dr. Fredrickson highlighted the company's focus on oncology and its commitment to partnering with governments to make a meaningful impact on cancer patients worldwide. One specific example he shared was AstraZeneca's strategic intent to address the high incidence of liver cancer in Egypt through innovative research and development efforts. By collaborating with the Egyptian Ministry of Health on early detection, timely diagnosis, and cost-effective treatment options, AstraZeneca aims to enhance the quality of care for liver cancer patients in the country.
